XML 180 R9.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Restricted shares
Restricted stock units
Total stockholders’ equity attributable to T. Rowe Price Group, Inc.
Total stockholders’ equity attributable to T. Rowe Price Group, Inc.
Restricted shares
Total stockholders’ equity attributable to T. Rowe Price Group, Inc.
Restricted stock units
Common stock
Common stock
Restricted shares
Common stock
Restricted stock units
Additional capital in excess of par value
Additional capital in excess of par value
Restricted shares
Additional capital in excess of par value
Restricted stock units
Retained earnings
AOCI
 [1]
Non-controlling interests in consolidated entities
Beginning balances (in shares) at Dec. 31, 2021             229,175,000                
Beginning balances at Dec. 31, 2021 $ 9,271.4     $ 9,022.7     $ 45.8     $ 919.8     $ 8,083.6 $ (26.5) $ 248.7
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 1,535.0     1,557.9                 1,557.9   (22.9)
Other comprehensive income (loss), net of tax (26.5)     (26.5)                   (26.5)  
Dividends declared (1,108.7)     (1,108.7)                 (1,108.7)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             522,000                
Shares issued upon option exercises 28.3     28.3     $ 0.1     28.2          
Issuance during period (in shares)               9,000 1,355,000            
Issuance during period     $ (64.3)     $ (64.3)     $ 0.3     $ (64.6)      
Stock-based compensation expense 285.4     285.4           285.4          
Restricted stock units issued as dividend equivalents 0.0     0.0           0.5     (0.5)    
Common shares repurchased (in shares)             (6,751,000)                
Common shares repurchased (855.3)     (855.3)     $ (1.3)     (731.4)     (122.6)    
Net distributions to non-controlling interests in consolidated entities (35.1)                           (35.1)
Ending balances (in shares) at Dec. 31, 2022             224,310,000                
Ending balances at Dec. 31, 2022 9,030.2     8,839.5     $ 44.9     437.9     8,409.7 (53.0) 190.7
Beginning balances attributable to redeemable non-controlling interests at Dec. 31, 2021 982.3                            
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) (108.3)                            
Other comprehensive income (loss), net of tax (21.0)                            
Net redemptions from consolidated investment products (49.3)                            
Net deconsolidations of investment products (147.0)                            
Ending balances attributable to redeemable non-controlling interests at Dec. 31, 2022 656.7                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 1,833.3     1,788.7                 1,788.7   44.6
Other comprehensive income (loss), net of tax 5.5     5.5                   5.5  
Special cash dividend declared (1,121.9)     (1,121.9)                 (1,121.9)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares)             585,000                
Shares issued upon option exercises 35.7     35.7     $ 0.1     35.6          
Issuance during period (in shares)               57,000 1,413,000            
Issuance during period     (53.7)     (53.7)     $ 0.3     (54.0)      
Stock-based compensation expense 265.6     265.6           265.6          
Restricted stock units issued as dividend equivalents 0.0     0.0           0.4     (0.4)    
Common shares repurchased (in shares)             (2,427,000)                
Common shares repurchased (254.3)     (254.3)     $ (0.5)     (253.8)        
Net distributions to non-controlling interests in consolidated entities (43.3)                           (43.3)
Ending balances (in shares) at Dec. 31, 2023             223,938,000                
Ending balances at Dec. 31, 2023 9,697.1     9,505.1     $ 44.8     431.7     9,076.1 (47.5) 192.0
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 47.0                            
Other comprehensive income (loss), net of tax 12.7                            
Net subscriptions into consolidated investment products 356.9                            
Net deconsolidations of investment products (479.2)                            
Ending balances attributable to redeemable non-controlling interests at Dec. 31, 2023 594.1                            
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Net income (loss) 2,105.5     2,100.1                 2,100.1   5.4
Other comprehensive income (loss), net of tax (4.2)     (4.2)                   (4.2)  
Special cash dividend declared $ (1,135.2)     (1,135.2)                 (1,135.2)    
Common stock-based compensation plans activity:                              
Shares issued upon option exercises (in shares) 812,959           577,000                
Shares issued upon option exercises $ 36.4     36.4     $ 0.1     36.3          
Issuance during period (in shares)               7,000 1,415,000            
Issuance during period   $ (0.3) $ (69.3)   $ (0.3) $ (69.3)     $ 0.3   $ (0.3) $ (69.6)      
Stock-based compensation expense 247.3     247.3           247.3          
Restricted stock units issued as dividend equivalents 0.0     0.0           0.4     (0.4)    
Common shares repurchased (in shares)             (2,971,000)                
Common shares repurchased (334.5)     (334.5)     $ (0.6)     (333.9)          
Net distributions to non-controlling interests in consolidated entities (36.7)     0.0                     (36.7)
Ending balances (in shares) at Dec. 31, 2024             222,966,000                
Ending balances at Dec. 31, 2024 10,506.1     $ 10,345.4     $ 44.6     $ 311.9     $ 10,040.6 $ (51.7) $ 160.7
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Net income (loss) 35.7                            
Other comprehensive income (loss), net of tax (5.0)                            
Net subscriptions into consolidated investment products 592.0                            
Net deconsolidations of investment products (272.8)                            
Ending balances attributable to redeemable non-controlling interests at Dec. 31, 2024 $ 944.0                            
[1] Accumulated other comprehensive income